Skip to main content
Log in

Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Evidence exists demonstrating that infection with hepatitis C virus impairs health-related quality of life, but less is known about the effect of fatigue, a common symptom, on everyday life. The psychometric properties of the fatigue severity scale (FSS) were explored to determine suitability as an outcome measure in clinical trials. The FSS includes nine items developed to measure disabling fatigue and a visual analog scale (VAS) to measure overall fatigue. Using baseline data from three clinical trials (n = 1225) involving chronic hepatitis C patients, scaling and psychometric characteristics of the FSS were assessed. The SF-36 was also used in the trials. Item response theory analysis demonstrated that the FSS items can be placed along a single homogenous domain, fatigue. Internal consistency reliability was 0.94. Test–retest reliability was 0.82 for the total score and 0.80 for the VAS. The total score and the VAS were significantly correlated with the SF-36 vitality subscale (r = −0.76 and r = −0.76 respectively). Correlations with other SF-36 subscales were moderate (r = −0.46 to r = −0.67, all p < 0.0001). In summary, the FSS possesses good psychometric properties.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. WHO Consultation. Global surveillance and control of hepatitis C: Report of a WHO consultation organized in collaboration with the viral hepatitis prevention board, Antwerp, Belgium. J Viral Hepat 1999; 6: 35–47.

    Article  Google Scholar 

  2. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26 (Suppl 1): 62S–65S.

    Article  PubMed  CAS  Google Scholar 

  3. Carithers RL, Sugano D, Bayliss M. Health assessment for chronic HCV infection: Results of quality of life. Dig Dis Sci 1996; 41: 75S–80S.

    Article  PubMed  Google Scholar 

  4. Davis GL, Balart MD, SchiffER, et al. Assessing health-related quality of life in chronic hepatitis C using the sickness impact profile. Clin Ther 1994; 16: 334–343.

    PubMed  CAS  Google Scholar 

  5. Ware JE, Bungay K, Bandek B, Bayliss M. Assessment of the health-related quality of life (HRQL) of patients with chronic hepatitis C (CHC) [Abstract]. Gastroenterology 1994; 106: A393.

    Google Scholar 

  6. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27: 209–212.

    Article  PubMed  CAS  Google Scholar 

  7. Bonkovsky HL, Woolley JM, the Consensus Interferon Study Group. Reduction of health-related quality of life in HCV and improvement with interferon therapy. Hepatology 1999; 29: 264–270.

    Article  PubMed  CAS  Google Scholar 

  8. Neary MP, Cort S, Bayliss MS, Ware JE. Sustained virologic response is associated with improved health-related quality of life in relapsed chronic Hepatitis C patients. Semin Liver Dis 1999; 19 (Suppl 1): 77–85.

    PubMed  Google Scholar 

  9. Ware JE, Bayliss MS, Mannocchia M, Davis GL, the International Hepatitis Interventional Therapy Group. Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response. Hepatology 1999; 30: 550–555.

    Article  PubMed  Google Scholar 

  10. Barkhuizen A, Rosen HR, Wolf S, Flora K, Benner K, Bennett RM. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: A report of 239 hepatology clinic patients. Am J Gastroenterol 1999; 94: 1355–1360.

    PubMed  CAS  Google Scholar 

  11. Kenny-Walsh E. Clinical outcomes after hepatitisCinfection from contaminated anti-D immune globulin. Irish hepatology research group. N Engl J Med 1999; 340: 1228–1233.

    Article  PubMed  CAS  Google Scholar 

  12. Dusheiko B. Side effects of a interferon in chronic hepatitis C. Hepatology 1997; 26 (Suppl 1): 112S–121S.

    Article  PubMed  CAS  Google Scholar 

  13. Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27 (Suppl): S217–S232.

    PubMed  CAS  Google Scholar 

  14. Nelles S, Abbey S, Stewart DE, Margulies M, Wanless IR, Heathcote EJ. Fatigue assessment in patients with hepatitis C [Abstract]. Gastroenterology 1996; 110(4): A1276.

    Google Scholar 

  15. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The Fatigue Severity Scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121–1123.

    PubMed  CAS  Google Scholar 

  16. Grey-Amante P, Wild D, Hakim Z, et al. The cross-cultural adaptation of the fatigue severity scale. Poster Presentation, Annual Drug Information Association Quality of Life Meeting, Hilton Head, SC. April 2–4, 2000.

  17. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993.

    Google Scholar 

  18. Hunt SM. Cross-cultural issues in the use of quality of life measures in randomized controlled trials. In: Staquet MJ, Hays RD, Fayers PM (eds) Quality of Life Assessment in Clinical Trials, Oxford: Oxford University Press, 1998: 51–68.

    Google Scholar 

  19. Ware JE, Kosinski M, Keller S. SF-36 Physical and Mental Health Summary Scores: A User's Manual. Boston: The Health Institute, New England Medical Center, 1994.

    Google Scholar 

  20. Streiner DL, Norman, GR. Health Measurement Scales: A Practical Guide to Their Development and Use, 2nd ed. New York: Oxford University Press, 1995.

    Google Scholar 

  21. Cella DF, Loyd SR, Wright BD. Cross-cultural instrument equating: Current research and future directions. Pages 707–716 in Spilker B. Quality of Life and Pharmacoeconomics in Clinical Trials, Second Edition. Philadelphia, PA: Lippincott-Raven Publishers, 1996.

    Google Scholar 

  22. Hambleton RK, Swaminathan H, Rogers HJ. Fundamentals of Item Response Theory. Newbury Park, CA: Sage Publications, 1991.

    Google Scholar 

  23. Samejima F. Estimation of latent trait ability using a response pattern of graded scores. Psychometrika Monograph Supplement 1969; 17: No. 17.

    Google Scholar 

  24. Mauraki E, Block RD. PARSCALE: IRT-based Tested Scoring and Item Analysis for Graded Open-ended Exercises and Performance Tasks. Chicago, IL: Scientific Software International, 1996.

    Google Scholar 

  25. Nunally JC, Bernstein IH. Psychometric Theory, 3rd ed. New York: McGraw-Hill, 1994.

    Google Scholar 

  26. Hays RD, Anderson RT, Revicki D. Assessing reliability and validity of measurement in clinical trials. In: Staquet MJ, Hays RD, Fayers PM (eds) Quality of Life Assessment in Clinical Trials: Methods and Practice, Oxford: Oxford University Press, 1998: 169–182.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kleinman, L., Zodet, M., Hakim, Z. et al. Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C. Qual Life Res 9, 499–508 (2000). https://doi.org/10.1023/A:1008960710415

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008960710415

Navigation